China is easing its drive for pharmaceutical self-sufficiency, increasingly relying on American-made medicines as soaring demand and supply chain hurdles transform the industry, according to a Wall Street Journal report
China is easing its drive for pharmaceutical self-sufficiency, increasingly relying on American-made medicines as soaring demand and supply chain hurdles transform the industry, according to a Wall Street Journal report
